Investor Overview

Corporate Profile

HTG Molecular Diagnostics, Inc's. (“HTG”) mission is to empower precision medicine at the local level. In 2013, the company commercialized its HTG Edge instrument platform and a portfolio of multiplexed profiling panels that leverage HTG’s proprietary target protection chemistry. In 2014, the company launched the HTG EdgeSeq system that combines the power of HTG Edge chemistry and automation with NGS technology. The HTG EdgeSeq system enables fast and easy use of NGS instruments for molecular profiling.

Stock Quote

HTGM (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$1.23
Change (%) Stock is Down 0.03 (2.38%)
Volume40,420
Data as of 02/24/17 3:58 p.m. ET

Recent News

01/05/17
HTG Molecular Diagnostics Completes Module Three Filing for HTG EdgeSeq ALKPlus Assay PMA
11/16/16
HTG Molecular Diagnostics and QIAGEN Team Up to Advance Precision Diagnostics
11/14/16
HTG Molecular Diagnostics Reports Third Quarter 2016 Results
Download PDF
 
11/03/16
HTG Molecular Diagnostics to Hold 2016 Third Quarter Financial Results Conference Call on November 14, 2016
More News >>

Upcoming Events

There are currently no events scheduled.
More Events >>
Data provided by Nasdaq. Minimum 15 minutes delayed.

Shareholder Tools

Print Page Print Page   E-mail Page E-mail Page   RSS Feeds RSS Feeds   E-mail Alerts E-mail Alerts